| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 30 | 2024 | 110 | 10.380 |
Why?
|
| Retinal Vessels | 21 | 2021 | 72 | 4.860 |
Why?
|
| Retina | 33 | 2024 | 433 | 4.530 |
Why?
|
| Diabetes Mellitus, Experimental | 20 | 2024 | 96 | 3.520 |
Why?
|
| Endothelial Cells | 15 | 2024 | 362 | 3.080 |
Why?
|
| Sphingomyelin Phosphodiesterase | 8 | 2020 | 13 | 2.120 |
Why?
|
| Ceramides | 6 | 2024 | 24 | 1.900 |
Why?
|
| Docosahexaenoic Acids | 7 | 2018 | 91 | 1.510 |
Why?
|
| Diabetes Mellitus | 5 | 2023 | 215 | 1.490 |
Why?
|
| Animals | 56 | 2024 | 10399 | 1.410 |
Why?
|
| Tight Junctions | 3 | 2023 | 29 | 1.400 |
Why?
|
| Circadian Rhythm | 9 | 2020 | 76 | 1.350 |
Why?
|
| Complement Activation | 2 | 2020 | 25 | 1.250 |
Why?
|
| Rats | 25 | 2024 | 1564 | 1.200 |
Why?
|
| Mice | 33 | 2024 | 4645 | 1.080 |
Why?
|
| Hyperglycemia | 4 | 2014 | 78 | 1.070 |
Why?
|
| Endothelium, Vascular | 6 | 2010 | 325 | 1.040 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 149 | 0.990 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 633 | 0.980 |
Why?
|
| Cholesterol | 8 | 2023 | 200 | 0.940 |
Why?
|
| Blood-Retinal Barrier | 4 | 2020 | 27 | 0.890 |
Why?
|
| Bone Marrow | 7 | 2020 | 76 | 0.880 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 133 | 0.860 |
Why?
|
| Fasting | 3 | 2021 | 81 | 0.850 |
Why?
|
| alpha-Cyclodextrins | 1 | 2023 | 3 | 0.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 330 | 0.830 |
Why?
|
| Oxysterols | 1 | 2023 | 3 | 0.820 |
Why?
|
| Capillary Permeability | 4 | 2018 | 53 | 0.810 |
Why?
|
| Cytokines | 5 | 2013 | 445 | 0.800 |
Why?
|
| Aldehyde Reductase | 4 | 2014 | 7 | 0.790 |
Why?
|
| Immunotherapy | 1 | 2024 | 158 | 0.780 |
Why?
|
| Diabetic Angiopathies | 2 | 2021 | 48 | 0.770 |
Why?
|
| MicroRNAs | 3 | 2016 | 295 | 0.750 |
Why?
|
| RNA, Messenger | 12 | 2023 | 656 | 0.740 |
Why?
|
| Eye Proteins | 3 | 2018 | 205 | 0.730 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 75 | 0.730 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2021 | 11 | 0.720 |
Why?
|
| Disease Models, Animal | 15 | 2023 | 1461 | 0.720 |
Why?
|
| Microvessels | 3 | 2018 | 87 | 0.720 |
Why?
|
| Cells, Cultured | 14 | 2021 | 985 | 0.710 |
Why?
|
| Retinal Neovascularization | 3 | 2018 | 20 | 0.700 |
Why?
|
| Male | 31 | 2024 | 13487 | 0.700 |
Why?
|
| Interleukin-1beta | 6 | 2024 | 43 | 0.690 |
Why?
|
| Glucose | 8 | 2008 | 203 | 0.680 |
Why?
|
| Phospholipids | 3 | 2017 | 76 | 0.680 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2020 | 16 | 0.660 |
Why?
|
| Pigment Epithelium of Eye | 3 | 2008 | 15 | 0.660 |
Why?
|
| Bone Marrow Cells | 3 | 2020 | 80 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 1570 | 0.640 |
Why?
|
| Lipids | 4 | 2022 | 208 | 0.640 |
Why?
|
| Extracellular Vesicles | 1 | 2020 | 42 | 0.630 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2017 | 94 | 0.630 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2023 | 113 | 0.630 |
Why?
|
| Humans | 39 | 2024 | 28121 | 0.620 |
Why?
|
| Transfection | 3 | 2015 | 318 | 0.600 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2014 | 58 | 0.590 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2018 | 178 | 0.580 |
Why?
|
| Inflammation | 4 | 2020 | 626 | 0.560 |
Why?
|
| CLOCK Proteins | 3 | 2014 | 3 | 0.560 |
Why?
|
| Membrane Fluidity | 1 | 2017 | 5 | 0.550 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 451 | 0.540 |
Why?
|
| Dyslipidemias | 1 | 2017 | 32 | 0.540 |
Why?
|
| Signal Transduction | 6 | 2021 | 1433 | 0.540 |
Why?
|
| Blotting, Western | 10 | 2017 | 510 | 0.530 |
Why?
|
| Cattle | 5 | 2023 | 389 | 0.520 |
Why?
|
| Membrane Proteins | 2 | 2018 | 485 | 0.520 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 270 | 0.520 |
Why?
|
| Exosomes | 1 | 2018 | 91 | 0.520 |
Why?
|
| Lactic Acid | 2 | 2015 | 92 | 0.500 |
Why?
|
| Wnt3A Protein | 1 | 2015 | 6 | 0.480 |
Why?
|
| Corneal Neovascularization | 1 | 2015 | 3 | 0.480 |
Why?
|
| Receptors, LDL | 1 | 2015 | 28 | 0.480 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2014 | 66 | 0.470 |
Why?
|
| Polyglycolic Acid | 1 | 2015 | 38 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2020 | 543 | 0.470 |
Why?
|
| Cornea | 1 | 2015 | 68 | 0.460 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 57 | 0.460 |
Why?
|
| Stem Cells | 2 | 2013 | 122 | 0.450 |
Why?
|
| Retinitis | 1 | 2014 | 9 | 0.450 |
Why?
|
| Acetyltransferases | 3 | 2009 | 36 | 0.440 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2014 | 9 | 0.440 |
Why?
|
| Macular Degeneration | 3 | 2022 | 84 | 0.420 |
Why?
|
| Neonatal Screening | 4 | 2016 | 13 | 0.410 |
Why?
|
| Liver X Receptors | 4 | 2021 | 22 | 0.400 |
Why?
|
| Capillaries | 2 | 2017 | 33 | 0.400 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2017 | 59 | 0.400 |
Why?
|
| Mice, Knockout | 5 | 2024 | 845 | 0.390 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 248 | 0.380 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2020 | 97 | 0.380 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2010 | 20 | 0.370 |
Why?
|
| Sirtuin 1 | 3 | 2023 | 41 | 0.360 |
Why?
|
| Cell Death | 3 | 2021 | 118 | 0.360 |
Why?
|
| Nanoparticles | 1 | 2015 | 288 | 0.360 |
Why?
|
| Diabetic Neuropathies | 2 | 2009 | 14 | 0.340 |
Why?
|
| Cell Adhesion Molecules | 3 | 2009 | 66 | 0.330 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2023 | 129 | 0.330 |
Why?
|
| Microglia | 3 | 2018 | 64 | 0.290 |
Why?
|
| Wound Infection | 2 | 2017 | 13 | 0.280 |
Why?
|
| Pseudomonas Infections | 2 | 2017 | 25 | 0.280 |
Why?
|
| Fatty Acids | 4 | 2023 | 204 | 0.280 |
Why?
|
| Gene Expression | 2 | 2021 | 414 | 0.270 |
Why?
|
| Caveolae | 1 | 2007 | 8 | 0.270 |
Why?
|
| Disease Progression | 3 | 2018 | 473 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2017 | 123 | 0.260 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 39 | 0.260 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 283 | 0.260 |
Why?
|
| Monocytes | 3 | 2016 | 135 | 0.250 |
Why?
|
| Biofilms | 2 | 2017 | 121 | 0.250 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2018 | 90 | 0.250 |
Why?
|
| Female | 15 | 2024 | 15156 | 0.240 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2018 | 126 | 0.230 |
Why?
|
| Vitreous Body | 1 | 2024 | 22 | 0.220 |
Why?
|
| Retinopathy of Prematurity | 2 | 2018 | 38 | 0.220 |
Why?
|
| Cell Movement | 4 | 2016 | 369 | 0.220 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2018 | 26 | 0.220 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 37 | 0.210 |
Why?
|
| Cytoskeleton | 2 | 2017 | 44 | 0.210 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 509 | 0.210 |
Why?
|
| Cholesterol 24-Hydroxylase | 2 | 2022 | 2 | 0.210 |
Why?
|
| Sterols | 1 | 2023 | 3 | 0.210 |
Why?
|
| Interleukin-6 | 3 | 2020 | 193 | 0.200 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 76 | 0.200 |
Why?
|
| Cerebral Palsy | 2 | 2012 | 31 | 0.200 |
Why?
|
| Swine | 1 | 2023 | 237 | 0.190 |
Why?
|
| Liver | 6 | 2014 | 434 | 0.190 |
Why?
|
| Fibric Acids | 1 | 2022 | 2 | 0.190 |
Why?
|
| Biomarkers | 2 | 2018 | 755 | 0.190 |
Why?
|
| Mitochondria | 2 | 2020 | 366 | 0.190 |
Why?
|
| Monosaccharide Transport Proteins | 4 | 2003 | 23 | 0.190 |
Why?
|
| Retinal Neurons | 1 | 2021 | 13 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 15 | 0.180 |
Why?
|
| Blood Specimen Collection | 2 | 2012 | 14 | 0.180 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2007 | 165 | 0.170 |
Why?
|
| Cholic Acids | 1 | 2020 | 1 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 82 | 0.170 |
Why?
|
| Pancreas | 3 | 2000 | 61 | 0.170 |
Why?
|
| Apoptosis | 1 | 2024 | 771 | 0.170 |
Why?
|
| Chronobiology Disorders | 1 | 2020 | 1 | 0.170 |
Why?
|
| Complement C1 | 1 | 2020 | 3 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 3 | 2016 | 101 | 0.170 |
Why?
|
| Nitric Oxide | 3 | 2012 | 152 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 108 | 0.170 |
Why?
|
| Immunoglobulins | 1 | 2020 | 34 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 133 | 0.170 |
Why?
|
| Cell Survival | 2 | 2020 | 407 | 0.170 |
Why?
|
| Fatty Acid Desaturases | 3 | 2010 | 15 | 0.160 |
Why?
|
| Wound Healing | 2 | 2017 | 125 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2020 | 66 | 0.160 |
Why?
|
| Autophagy | 1 | 2020 | 71 | 0.160 |
Why?
|
| Ultracentrifugation | 1 | 2018 | 8 | 0.150 |
Why?
|
| Dysbiosis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Rats, Long-Evans | 2 | 2017 | 34 | 0.150 |
Why?
|
| Complement System Proteins | 1 | 2018 | 24 | 0.150 |
Why?
|
| Claudin-5 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Occludin | 1 | 2018 | 11 | 0.150 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2018 | 17 | 0.140 |
Why?
|
| Dipeptides | 1 | 2018 | 22 | 0.140 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 12 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2018 | 34 | 0.140 |
Why?
|
| Pancreatic Ducts | 1 | 1997 | 10 | 0.140 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 2014 | 3 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 605 | 0.140 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 2 | 0.140 |
Why?
|
| ARNTL Transcription Factors | 1 | 2017 | 2 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 163 | 0.140 |
Why?
|
| Neointima | 1 | 2017 | 4 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 31 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 14 | 0.140 |
Why?
|
| Chromaffin Cells | 1 | 1996 | 2 | 0.130 |
Why?
|
| Ependymoglial Cells | 1 | 2017 | 32 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1996 | 22 | 0.130 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 34 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2016 | 32 | 0.130 |
Why?
|
| Calcium | 2 | 1996 | 235 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 122 | 0.130 |
Why?
|
| Chimera | 1 | 2016 | 3 | 0.130 |
Why?
|
| RNA Interference | 1 | 2016 | 137 | 0.130 |
Why?
|
| Sphingolipids | 1 | 2016 | 20 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cell Count | 1 | 2016 | 86 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 49 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 190 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 112 | 0.120 |
Why?
|
| Rats, Wistar | 3 | 2013 | 151 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 268 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 260 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 192 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 155 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2009 | 311 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 245 | 0.110 |
Why?
|
| Liquid-Liquid Extraction | 1 | 2014 | 3 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2014 | 14 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2017 | 198 | 0.110 |
Why?
|
| Middle Aged | 5 | 2017 | 7164 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2016 | 143 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2014 | 63 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2013 | 6 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2014 | 115 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2013 | 37 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 1993 | 40 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 26 | 0.110 |
Why?
|
| Imidazoles | 1 | 1993 | 63 | 0.110 |
Why?
|
| Sympathetic Nervous System | 2 | 2013 | 68 | 0.110 |
Why?
|
| Dried Blood Spot Testing | 1 | 2012 | 3 | 0.100 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
| Aged | 3 | 2018 | 5416 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2012 | 68 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2016 | 873 | 0.100 |
Why?
|
| Obesity | 2 | 2009 | 668 | 0.090 |
Why?
|
| Microfilament Proteins | 2 | 2009 | 28 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2003 | 123 | 0.090 |
Why?
|
| Caspases | 2 | 2008 | 42 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2002 | 46 | 0.090 |
Why?
|
| Leptin | 2 | 2009 | 67 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2009 | 116 | 0.090 |
Why?
|
| Leukocytes | 2 | 2018 | 71 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 58 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2010 | 55 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2010 | 35 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2009 | 32 | 0.080 |
Why?
|
| Denervation | 1 | 2009 | 10 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 71 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 65 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2017 | 55 | 0.080 |
Why?
|
| Weight Gain | 1 | 2009 | 74 | 0.080 |
Why?
|
| Phosphatidylethanolamines | 1 | 2009 | 26 | 0.080 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2008 | 5 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 131 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 326 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 198 | 0.080 |
Why?
|
| Neuroglia | 1 | 2008 | 30 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2009 | 191 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 166 | 0.070 |
Why?
|
| Electromagnetic Phenomena | 1 | 2008 | 15 | 0.070 |
Why?
|
| Carbon Monoxide | 1 | 2008 | 47 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2008 | 136 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2008 | 24 | 0.070 |
Why?
|
| Superoxides | 1 | 2008 | 61 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2008 | 575 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2017 | 118 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2009 | 138 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 121 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 116 | 0.070 |
Why?
|
| Fura-2 | 3 | 1996 | 10 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 20 | 0.070 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 9 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2018 | 180 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2017 | 71 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2007 | 71 | 0.070 |
Why?
|
| Sphingomyelins | 2 | 2020 | 11 | 0.060 |
Why?
|
| Aging | 1 | 2013 | 976 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2005 | 23 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 50 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2008 | 663 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2002 | 15 | 0.060 |
Why?
|
| Fish Oils | 1 | 2005 | 12 | 0.060 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2017 | 804 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 121 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2003 | 3 | 0.050 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2003 | 16 | 0.050 |
Why?
|
| Carbachol | 2 | 1993 | 18 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 25 | 0.050 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2022 | 1 | 0.050 |
Why?
|
| Diet | 1 | 2005 | 231 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2003 | 56 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 156 | 0.050 |
Why?
|
| Nocodazole | 1 | 2002 | 11 | 0.050 |
Why?
|
| Dehydroascorbic Acid | 1 | 2002 | 1 | 0.050 |
Why?
|
| Endothelium | 1 | 2002 | 28 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2002 | 67 | 0.050 |
Why?
|
| Microtubules | 1 | 2002 | 91 | 0.050 |
Why?
|
| Adult | 4 | 2018 | 7757 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2012 | 76 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 257 | 0.040 |
Why?
|
| Secretory Vesicles | 1 | 2000 | 12 | 0.040 |
Why?
|
| Exocytosis | 1 | 2000 | 13 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2012 | 722 | 0.040 |
Why?
|
| Desipramine | 1 | 2020 | 4 | 0.040 |
Why?
|
| 3-O-Methylglucose | 1 | 2000 | 2 | 0.040 |
Why?
|
| Galactose | 1 | 2000 | 6 | 0.040 |
Why?
|
| Citrate (si)-Synthase | 1 | 2020 | 23 | 0.040 |
Why?
|
| DNA Probes | 1 | 2000 | 13 | 0.040 |
Why?
|
| Phenotype | 2 | 2012 | 679 | 0.040 |
Why?
|
| Rats, Inbred BB | 1 | 2020 | 1 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2020 | 29 | 0.040 |
Why?
|
| Pregnancy | 2 | 2018 | 1181 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 151 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1999 | 5 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 1593 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 73 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 86 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 1996 | 90 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 1137 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2000 | 257 | 0.040 |
Why?
|
| Verrucomicrobia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2018 | 14 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 773 | 0.040 |
Why?
|
| Ganglia, Sensory | 1 | 2018 | 3 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2018 | 30 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2018 | 15 | 0.040 |
Why?
|
| Bacteroidetes | 1 | 2018 | 16 | 0.040 |
Why?
|
| Firmicutes | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 58 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2018 | 22 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1997 | 10 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1997 | 28 | 0.040 |
Why?
|
| Rejuvenation | 1 | 2017 | 26 | 0.040 |
Why?
|
| Microorganisms, Genetically-Modified | 1 | 2017 | 1 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 78 | 0.040 |
Why?
|
| Drug Design | 1 | 2018 | 63 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 189 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 289 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 109 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 17 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 25 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2017 | 27 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 120 | 0.030 |
Why?
|
| Amylases | 2 | 1993 | 4 | 0.030 |
Why?
|
| Sincalide | 2 | 1993 | 4 | 0.030 |
Why?
|
| Perfusion | 2 | 1993 | 43 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 315 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1996 | 31 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2017 | 58 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1996 | 62 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 197 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1993 | 242 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 233 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 465 | 0.030 |
Why?
|
| Child | 2 | 2012 | 2242 | 0.030 |
Why?
|
| Action Potentials | 1 | 1996 | 195 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 462 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 3123 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2006 | 126 | 0.030 |
Why?
|
| Alu Elements | 1 | 2013 | 2 | 0.030 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2013 | 2 | 0.030 |
Why?
|
| Minocycline | 1 | 2013 | 7 | 0.030 |
Why?
|
| Procaine | 1 | 1993 | 2 | 0.030 |
Why?
|
| RNA, Double-Stranded | 1 | 2013 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 14 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 21 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2013 | 26 | 0.030 |
Why?
|
| Electroretinography | 1 | 2014 | 178 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 66 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 93 | 0.030 |
Why?
|
| Permeability | 1 | 2012 | 61 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 1 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2012 | 9 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 56 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 141 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2012 | 31 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 60 | 0.020 |
Why?
|
| Light Coagulation | 1 | 2011 | 2 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2011 | 8 | 0.020 |
Why?
|
| Lasers | 1 | 2011 | 67 | 0.020 |
Why?
|
| Neurons | 1 | 2013 | 282 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 475 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 125 | 0.020 |
Why?
|
| Biological Transport | 2 | 2002 | 120 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 413 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 110 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 24 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 180 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 677 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 33 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 67 | 0.020 |
Why?
|
| Mesentery | 1 | 2009 | 10 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2009 | 13 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2009 | 25 | 0.020 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2008 | 1 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 45 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 28 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 42 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 50 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 848 | 0.020 |
Why?
|
| Vasodilation | 1 | 2009 | 114 | 0.020 |
Why?
|
| Astrocytes | 1 | 2009 | 77 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 124 | 0.020 |
Why?
|
| Microcirculation | 1 | 2008 | 112 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 288 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 464 | 0.020 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2006 | 5 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2006 | 21 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2006 | 15 | 0.020 |
Why?
|
| Kinetics | 2 | 2000 | 545 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2006 | 33 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2008 | 206 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2006 | 73 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 825 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2005 | 82 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 315 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 11 | 0.010 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2003 | 4 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 2003 | 12 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 65 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 200 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 77 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2003 | 62 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 12 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 24 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2002 | 21 | 0.010 |
Why?
|
| Microscopy, Interference | 1 | 2000 | 1 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2000 | 18 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2000 | 74 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2000 | 73 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 285 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1999 | 9 | 0.010 |
Why?
|
| Scopolamine Derivatives | 1 | 1993 | 1 | 0.010 |
Why?
|
| N-Methylscopolamine | 1 | 1993 | 1 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1993 | 9 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1993 | 13 | 0.010 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1993 | 5 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1993 | 62 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1993 | 36 | 0.010 |
Why?
|